The Department of Health and Human Services is suing Gilead Sciences over the patent rights to Truvada, Gileads HIV prevention drug better known as PrEP, or pre-exposure prophylaxis.
PrEP is a pill taken once daily that is 99 percent effective at preventing …

Click here to view the original article.